Lymphoproliferative lung disorders: clinicopathological aspects

Poletti Venerino, Ravaglia Claudia, Tomassetti Sara, Gurioli Carlo, Casoni Gianluca, Asioli Silvia, Dubini Alessandra, Piciucchi Sara, Chilosi Marco

Source: Eur Respir Rev 2013; 22: 427-436
Journal Issue: December 2013 - 22 (130)

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Poletti Venerino, Ravaglia Claudia, Tomassetti Sara, Gurioli Carlo, Casoni Gianluca, Asioli Silvia, Dubini Alessandra, Piciucchi Sara, Chilosi Marco. Lymphoproliferative lung disorders: clinicopathological aspects. Eur Respir Rev 2013; 22: 427-436

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pancreatic disorders and lung manifestations
Source: International Congress 2017 – Respiratory manifestations of gastrointestinal diseases
Year: 2017


Lymphoproliferative disease and other malignancies
Source: ERS Course 2016
Year: 2016



Cytokines profile in granulomatous lung disorders
Source: Eur Respir J 2005; 26: Suppl. 49, 374s
Year: 2005

Pulmonary manifestations of endocrine and metabolic disorders
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=234
Year: 2005

Systemic disorders with lung involvement
Source: ERS Course 2018 - Summer school of paediatric respiratory medicine
Year: 2018

Early symptoms in lung cancer: the paraneoplasic syndromes
Source: Eur Respir J 2003; 22: Suppl. 45, 253s
Year: 2003

Amyloid-and nonamyloid-deposition disease in the lung: novel manifestations
Source: Annual Congress 2013 –Ceremony for ERS Award for Rare Pulmonary Disease (financially supported by GlaxoSmithKline) followed by Symposium: Autoimmunity and lung diseases in humans
Year: 2013


Immunodeficiencies in adulthood: lung disease manifestations and treatment options
Source: International Congress 2019 – PG6 Immunodeficiencies in lung diseases
Year: 2019


Clinicopathological features in thymoma-associated autoimmune disease
Source: Eur Respir J 2005; 26: Suppl. 49, 435s
Year: 2005

Progressive phenotype in primary Sjögren's syndrome-associated interstitial lung diseases: Prognostic significance
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020

Eosinophilic lung disease: clinical features of 25 patients
Source: Eur Respir J 2006; 28: Suppl. 50, 237s
Year: 2006

The characteristics of mycobacterioses in patients with chronic lung diseases
Source: International Congress 2019 – Airway infection in COPD
Year: 2019

Clinical and immunological peculiarities of bronchial asthma course in patients with thyroid gland disorders
Source: Eur Respir J 2004; 24: Suppl. 48, 511s
Year: 2004

Pulmonary manifestations of haematological diseases: from lymphoma to sickle cell crisis
Source: International Congress 2018 – Respiratory medicine meets hematology
Year: 2018


Sarcoidosis with extra-thoracic lesions: clinical aspects
Source: Eur Respir J 2002; 20: Suppl. 38, 435s
Year: 2002

Clinical features and outcomes of patients with myositis associated-interstitial lung disease
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021


Interstitial lung diseases and systemic disorders with lung involvement
Source: ERS Skills Course 2016
Year: 2016

Interstitial lung diseases and systemic disorders with lung involvement
Source: ERS Skills Course 2017 - Summer school of paediatric respiratory medicine
Year: 2017

Rare lung diseases in children: challenges for diagnosis and treatment
Source: Virtual Congress 2021 – Rare lung diseases 2021
Year: 2021